Navigation Links
Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders

SEATTLE, Aug. 31, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (the "Company") (NASDAQ and MTA: CTIC) announced today the results from its Annual Meeting of Shareholders (the "Annual Meeting") held on Friday, August 31, 2012.

At the Annual Meeting, shareholders elected Richard L. Love, Mary O. Mundinger, DrPH, and Jack W. Singer, M.D. to serve on the Company's Board of Directors until the Company's 2015 Annual Meeting. Shareholders approved an amendment to the Company's amended and restated articles of incorporation to increase the total number of authorized shares and authorized shares of common stock and approved an amendment to the Company's 2007 Equity Incentive Plan, as amended and restated (the "Plan"), to increase the number of shares available for issuance under the Plan. Shareholders also approved the shares issued to S*BIO Pte Ltd. ("S*BIO") in connection with, or to finance, the acquisition of assets of S*BIO and at the Company's option, to issue shares of common stock or shares of preferred stock in lieu of cash for up to 50% of the milestone payments pursuant to the asset purchase agreement entered into with S*BIO on April 18, 2012.  Shareholders additionally approved the issuance of shares of preferred stock and shares of common stock issuable upon conversion of the preferred stock, warrants and shares of common stock issuable upon the exercise of the warrants, and at the Company's option, the issuance of shares of common stock in lieu of cash upon exchange of such warrants issued to Socius CG II, Ltd. pursuant to the securities purchase agreement entered into in connection with the offering of Series 15 Convertible Preferred Stock on May 29, 2012. Shareholders ratified the selection of Marcum LLP as the Company's independent auditors for the year ending December 31, 2012.

About Cell Therapeutics, Inc. Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit

Sign up for email alerts and get RSS feeds at our Web site,

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results. Specifically, the risks and uncertainties include that the Company may not issue shares of common stock or shares of preferred stock in lieu of cash to S*BIO for milestone payments, that the Company may not issue shares of common stock in lieu of cash upon exchange of warrants issued to Socius CG II, Ltd., the risk factors listed or described from time to time in the Company's filings with the U.S. Securities and Exchange Commission including, without limitation, the Company's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, the Company does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.Media contact:Investors contact:Cell Therapeutics, Inc.Cell Therapeutics, Inc.Dan EramianEd BellT: 206.272.4343T: 206.272.4345F: 206.272.4434E: invest@ctiseattle.comE: 

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. MGC Diagnostics Corporation Reports Third Quarter Fiscal Year 2012 Operating Results
4. Groupe Athena Inc., (OTC: GATA) Reports Audited Financials, Announces Record Revenue & Profits
5. China Nepstar Chain Drugstore Reports Second Quarter 2012 Financial Results
6. China Kanghui Holdings Reports Second Quarter 2012 Financial Results
7. Concord Medical Reports Second Quarter 2012 Financial Results
8. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
9. Organovo Reports Q2 2012 Financial Results, Provides Business Update
10. ULURU Inc. Reports Second Quarter 2012 Financial Results
11. China Pharma Holdings, Inc. Reports Second Quarter 2012 Financial Results
Post Your Comments:
(Date:6/26/2016)... Story Highlights: ... the health care industry is causing providers to review ... Deloitte offers a suite of solutions for health care ... cost optimization: labor resource analysis, revenue cycle optimization and ... outcomes and better economics ...
(Date:6/24/2016)... June 24, 2016  Collagen Matrix, Inc., ("Collagen ... and manufacturing of collagen and mineral based medical ... that Bill Messer has joined the ... further leverage the growing portfolio of oral surgery, ... Bill joins the Collagen Matrix executive team ...
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the ... in the world, and the most handsome men, look naturally attractive. Plastic surgery ...
Breaking Medicine News(10 mins):